Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Banks Curb Hedge Fund Bets on SK Hynix, Samsung After Wild Moves
Global banks are curbing hedge funds’ leveraged bets on Asia’s top chipmakers including SK Hynix Inc. and Samsung Electronics Co. after a blistering rally this year raised concerns of a potential pullback, according to people familiar with the matter.
AB Group reaffirms bet on Voda Idea with ₹4,730 Cr infusion
Vodafone Idea shareholders approved a ₹4,730-crore investment from the Aditya Birla Group via preferential allotment of warrants, increasing AB Group's stake to around 13%. Chairman Kumar Mangalam Birla stated the company's focus now shifts to execution across operations, customer service, and network expansion. This capital infusion will support capital expenditure and loan repayment, reinforcing Vi's financial health.
Stock market today: Which are top 10 gainers and losers on NSE & BSE on June 11? Check list - The Times of India
Stock market today: Which are top 10 gainers and losers on NSE & BSE on June 11? Check listThe Times of India
Kospi tanks 9% in just two sessions! What’s causing bloodbath in 2026’s top market?
South Korea’s KOSPI has plunged 9% in two sessions after a strong 2026 rally, as AI-driven semiconductor stocks face profit booking. Rising U.S. inflation, geopolitical tensions in West Asia and leveraged ETF volatility have intensified the sell-off, raising concerns that the AI-led rally may have outpaced fundamentals.
Market Trading Guide: Akums Drugs among 4 stock recommendations for Thursday
Domestic equities ended lower amid global uncertainty and caution ahead of key US inflation data. Despite market weakness, analysts remain bullish on Akums Drugs and Aditya Birla Sun Life AMC after strong technical breakouts, rising volumes and improving momentum indicators.
Stock market today: Which are top 10 gainers and losers on NSE & BSE on June 10? Check list - The Times of India
Stock market today: Which are top 10 gainers and losers on NSE & BSE on June 10? Check listThe Times of India
Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.
SBI steps in with $1-billion funding for Sun Pharma’s Organon deal
The size of SBI’s funding for the $12-billion Sun Pharma-Organon deal underscores the growing appetite among state-run banks to back M&A deals by Indian companies.
SBI in $1 billion funding for Sun Pharma’s US deal
State Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co. This move marks a significant step for government-run banks in financing corporate takeovers. SBI will join other global lenders in this substantial deal. The funding underscores the growing ambition of Indian companies to expand globally.
Grasim announces ₹3,094-cr investment for lyocell capacity expansion in Karnataka plant
The expansion will add 110,000 TPA capacity at Harihar; total cellulosic staple fibre capacity slated to exceed one million tonnes annually by 2030. Grasim Industries, a Aditya Birla Group company, shares closed at ₹3,060.30 on the NSE on June 8, down 0.89%, or ₹27.40.
Wipro To Eternal: Top Laggards Behind The Stock Market Crash Today
The BSE Sensex declined 0.97% to close at 73,524.26, while the NSE Nifty 50 fell 1.04% to end at 23,123.